Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation is a research paper published in Journal of Neuro-Oncology (2022). On theSindex it has a DataRank of 0.782. It has been cited 16 times, with 13 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0.357
From 11 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 13 citers.
UCLA SPORE in Brain Cancer
Grant: NIH/NCI 1P50CA211015-01A1
American Cancer Society (ACS) Research Scholar Grant
Grant: RSG-15-003-01-CCE
NIH/NCI
Grant: 1R21CA223757-01
Metabolic MRI for quantifying aerobic glycolysis and immune function in gliomas
NCI NIH HHS
Grant: P50 CA211015
NCI NIH HHS
Grant: R01 CA270027
National Institutes of Health
Grant: 1P50CA211015-01A1
UCLA SPORE in Brain Cancer
University of California Research Coordinating Committee
UCLA Jonsson Comprehensive Cancer Center Seed Grant
FWCI
2.05
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords